Literature DB >> 1830394

Cellular delivery and retention of Photofrin II: the effects of interaction with human plasma proteins.

M Korbelik1, J Hung.   

Abstract

The absorbance and fluorescence spectra of Photofrin II (PII) in the presence of albumin, globulins and lipoproteins from human plasma show that all of these proteins induce a degree of disaggregation of PII material. In addition, there are substantial rearrangements in the distribution of different fractions contained in PII and their binding to the protein. It is shown that these rearrangements have considerable impact on the uptake of PII by cultured cells and the ensuing retention of the drug in the cells. The information on the contribution of fluorescing and non-fluorescing components of PII in the cells was obtained by measuring first the PII fluorescence in suspensions of live cells, followed by chemical extraction of porphyrin material from the same cells. The interaction of PII with low density lipoproteins resulted in markedly lower levels of PII material retained in the cells, compared to protein-free drug exposure. Somewhat better but still inferior PII retention was observed with high density lipoproteins. The samples with very low density lipoproteins showed increased uptake of PII, but the subsequent retention of the drug was low, so that the remaining amount of the drug was not much different than in protein-free samples. The strongest inhibition of PII uptake was seen with albumin, with ensuing retention of PII not significantly different than in protein-free samples. The best retention of PII was observed with globulins, with approx. 25% higher total drug content retained in the cells after long-term clearance relative to protein-free samples.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1830394     DOI: 10.1111/j.1751-1097.1991.tb03662.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  4 in total

1.  Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity.

Authors:  Yeissa Chabrier-Roselló; Thomas H Foster; Nelissa Pérez-Nazario; Soumya Mitra; Constantine G Haidaris
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 2.  Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection.

Authors:  Wanessa C M A de Melo; Pinar Avci; Milene Nóbrega de Oliveira; Asheesh Gupta; Daniela Vecchio; Magesh Sadasivam; Rakkiyappan Chandran; Ying-Ying Huang; Rui Yin; Livia R Perussi; George P Tegos; Janice R Perussi; Tianhong Dai; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-07       Impact factor: 5.091

Review 3.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

4.  Distribution of Photofrin between tumour cells and tumour associated macrophages.

Authors:  M Korbelik; G Krosl; P L Olive; D J Chaplin
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.